Multi-Omics Nutritional Approaches Targeting Metabolic-Associated Fatty Liver Disease

Abstract excerpt

Currently, metabolic-associated fatty liver disease (MAFLD) is a leading global cause of chronic liver disease, and is expected to become one of the most common indications of liver transplantation. MAFLD is associated with obesity, involving multiple mechanisms such as alterations in lipid metabolism, insulin resistance, hyperinflammation, mitochondrial dysfunction, cell apoptosis, oxidative stress, and...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Diet, Metabolism, and Disease
• Share to Liver Disease Diagnosis and Treatment
• Share to Metabolism and Genetic Disorders